{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:28:11Z","timestamp":1786429691446,"version":"build-2736575974"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Since February 2022, Ukraine has been facing the challenges of active armed conflict, undermining its healthcare system. Despite the ongoing war, the national cervical cancer screening program was launched in 2025. However, little is known about whether laboratory diagnostic quality can be maintained under these conditions. This study aimed to assess the resilience of cervical cancer screening services in Ukraine during wartime by evaluating the temporal dynamics of PAP smears, HPV testing, and their quality indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This single-center, repeated cross-sectional study included laboratory data collected on PAP smears from 946,451 cases and 114,974 HPV tests retrieved from the database of the Medical Laboratory CSD in 2021\u20132025. The Annual Bethesda System 2014 (BS 2014) category proportions and quality metrics (including the ASC\/SIL ratio and non-diagnostic rate) were assessed and compared with the benchmarks from BS 2014 and the College of American Pathologists (CAP). HPV testing data included overall positivity rates and HPV 16\/18 genotype distribution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The volume of PAP tests decreased by 21.5% in 2022; however, there was a significant recovery in 2023, with an increase of 85.3% in 2025 compared to the pre-war baseline (2021). Each Bethesda category proportion for every year aligned within international benchmark ranges. The five-year CSD medians were as follows: NILM\u201491.27% (89.24\u201391.61%); ASC-US\u20144.45% (3.94\u20135.38%); LSIL\u20142.83% (2.49\u20133.57%); HSIL\u20140.38% (0.31\u20130.62%), non-diagnostic\u20140.80% (0.54\u20131.03%); SCC\u20140.024% (0.016\u20130.051%); and AGC\u20140.25% (0.22\u20130.26%). Quality metrics were consistent with global reference values, with a total abnormal sample rate of 7.81% (7.7\u20139.67%), ASC\/SIL ratio of 1.36 (1.18\u20131.66), and ASC-US\/LSIL ratio of 1.47 (1.28\u20131.79). HPV testing expanded at a disproportionately higher rate than Pap test utilization, surging 27.8-fold over the wartime period. HPV positivity declined significantly from 21.07% in 2021 to 17.16% in 2025 (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.011). While HPV16 prevalence remained relatively stable, the relative contribution of HPV18 nearly doubled, rising from 5.6 to 10.4% among HPV-positive individuals (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.008).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cytopathological reporting patterns remained within benchmark ranges under 4\u202fyears of armed conflict in Ukraine, with diagnostic performance of CSD LAB corresponding to international benchmarks. The rapid HPV testing expansion associated with an increased rate of testing among younger women, a decline in HPV positivity among the 30\u201365 cohort, and a rise in the HPV 18 proportional rate have direct implications for national vaccination and screening policies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1909774","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:38:30Z","timestamp":1786426710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cervical screening under wartime: resilience and quality of laboratory services in Ukraine during the Russian invasion"],"prefix":"10.3389","volume":"14","author":[{"given":"Pavlina","family":"Botsun","sequence":"first","affiliation":[{"name":"Bogomolets National Medical University","place":["Kyiv, Ukraine"]},{"name":"Medical Laboratory CSD","place":["Kyiv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Omelianenko","sequence":"additional","affiliation":[{"name":"Bogomolets National Medical University","place":["Kyiv, Ukraine"]},{"name":"Medical Laboratory CSD","place":["Kyiv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurii","family":"Sava","sequence":"additional","affiliation":[{"name":"Bogomolets National Medical University","place":["Kyiv, Ukraine"]},{"name":"Medical Laboratory CSD","place":["Kyiv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Panko","sequence":"additional","affiliation":[{"name":"Bogomolets National Medical University","place":["Kyiv, Ukraine"]},{"name":"Medical Laboratory CSD","place":["Kyiv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larysa","family":"Natrus","sequence":"additional","affiliation":[{"name":"Bogomolets National Medical University","place":["Kyiv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazarii","family":"Kobyliak","sequence":"additional","affiliation":[{"name":"Bogomolets National Medical University","place":["Kyiv, Ukraine"]},{"name":"Medical Laboratory CSD","place":["Kyiv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Sulaieva","sequence":"additional","affiliation":[{"name":"Bogomolets National Medical University","place":["Kyiv, Ukraine"]},{"name":"Medical Laboratory CSD","place":["Kyiv, Ukraine"]},{"name":"Ukrainian Association for Precision Medicine","place":["Kyiv, Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jncc.2024.11.006","article-title":"Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022","volume":"5","author":"Wu","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"100436","DOI":"10.1016\/j.jcpo.2023.100436","article-title":"Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: a population-based survey","volume":"38","author":"Znaor","year":"2023","journal-title":"J Cancer Policy"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3332\/ECANCER.2020.1039","article-title":"The impact of armed conflict on cancer among civilian populations in low- and middle-income countries: a systematic review","volume":"14","author":"Jawad","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/CYT.13236","article-title":"The detrimental consequences of two consecutive disasters impacting cytopathology in Ukraine: COVID followed by the war","volume":"34","author":"Sulaieva","year":"2023","journal-title":"Cytopathology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1192\/BJI.2023.43","article-title":"Ukrainian healthcare providers under siege during the first year of war: challenges and adaptations","volume":"21","author":"Deac","year":"2024","journal-title":"BJPsych Int"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/S13031-025-00711-Y","article-title":"Research and conflict: mapping research trends and gaps in Ukrainian emergency medical services\u2014a scoping review","volume":"19","author":"Castro-Delgado","year":"2025","journal-title":"Confl Heal"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"11602","DOI":"10.3390\/SU151511602","article-title":"Ukraine\u2019s healthcare crisis: sustainable strategies for navigating conflict and rebuilding for a resilient future","volume":"15","author":"Goniewicz","year":"2023","journal-title":"Sustainability"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/JAMA.2022.6046","article-title":"Catastrophic health consequences of the war in Ukraine","volume":"327","author":"Fontanarosa","year":"2022","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"117504","DOI":"10.1016\/j.socscimed.2024.117504","article-title":"Psychosocial challenges of Ukrainian healthcare professionals in wartime: addressing the need for management support","volume":"364","author":"Sydorenko","year":"2025","journal-title":"Soc Sci Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1017\/DMP.2023.91","article-title":"Social and healthcare impacts of the Russian-led hybrid war in Ukraine\u2014a conflict with unique global consequences","volume":"17","author":"Khorram-Manesh","year":"2023","journal-title":"Disaster Med Public Health Prep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4236\/HEALTH.2023.156036","article-title":"Cervical cancer prevention challenges and barriers to cervical cancer screening and HPV vaccinations in Ukraine and Eastern Europe","volume":"15","author":"Osnytska","year":"2023","journal-title":"Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-11074-5","volume-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes","author":"Nayar","year":"2015"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5858\/134.3.331","article-title":"Practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology, 2006","volume":"134","author":"Eversole","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000442407","article-title":"Cervical cytology reporting rates from China\u2019s largest College of American Pathologists-certified laboratory with a focus on squamous cell carcinoma cytology and its histopathological follow-up results","volume":"59","author":"Zheng","year":"2015","journal-title":"Acta Cytol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.14218\/JCTP.2023.00004","article-title":"Updates in cervical Cancer screening guidelines, the Bethesda system for reporting cervical cytology, and clinical management recommendations","volume":"3","author":"Wang","year":"2023","journal-title":"J Clin Transl Pathol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"103008","DOI":"10.1016\/j.eclinm.2024.103008","article-title":"The impact of war on people with type 2 diabetes in Ukraine: a survey study","volume":"79","author":"Sulaieva","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/CNCY.22547","article-title":"COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: an international, multicenter study","volume":"130","author":"Vigliar","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1007\/S00268-022-06700-Z","article-title":"Armed conflicts destroy civilian health systems: Cancer screening in Ukraine the newest casualty of world conflict","volume":"46","author":"Wren","year":"2022","journal-title":"World J Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/S10552-025-02022-2","article-title":"Navigating cancer care in Ukraine: patient\u2019s coping strategies to ensure access and quality","volume":"36","author":"Levenets","year":"2025","journal-title":"Cancer Causes Control"},{"key":"ref23","year":""},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob Health"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMSR2030640","article-title":"The IARC perspective on cervical cancer screening","volume":"385","author":"Bouvard","year":"2021","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.31557\/APJCP.2023.24.5.1781","article-title":"HPV vaccination and cervical cancer screening policies and practices in 18 countries, territories and entities across Eastern Europe and Central Asia","volume":"24","author":"Davies","year":"2023","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1909774\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:38:31Z","timestamp":1786426711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1909774\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":27,"alternative-id":["10.3389\/fpubh.2026.1909774"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1909774","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"1909774"}}